1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Macias, M.J.
Gervais, V.
Civera, C.
Oschkinat, H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
7
375
10.1038/75144
10802733
Structural Analysis of Ww Domains and Design of a Ww Prototype
2000
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4364.709
FORMIN BINDING PROTEIN
DOMAIN
1
man
polymer
no
no
GATAVSEWTEYKTADGKTYYYNNRTLESTWEKPQELK
GATAVSEWTEYKTADGKTYYYNNRTLESTWEKPQELK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HOUSE MOUSE
sample
10090
MUS MUSCULUS
562
ESCHERICHIA COLI
repository
Initial release
Version format compliance
Version format compliance
1
0
2000-04-20
1
1
2011-05-08
1
2
2011-07-13
PROTOTYPE WW DOMAIN
YJQ8WW DOMAIN FROM SACCHAROMYCES CEREVISAE
NMR RESTRAINTS FOR THE ENTRY 1E0L
PDBE
Y
PDBE
2000-03-30
REL
THE STRUCTURE WAS DETERMINED USING HOMONUCLEAR NMR SPECTROSCOPY
LOWEST ENERGY
20
10
NOESY
TOCSY
6.5
pH
285
K
simulated annealing
1
1. NILGES, M.
refinement
ARIA/CNS
structure solution
ARIA CNS
CNS
600
Bruker
DRX
GLY
1
n
1
GLY
1
A
ALA
2
n
2
ALA
2
A
THR
3
n
3
THR
3
A
ALA
4
n
4
ALA
4
A
VAL
5
n
5
VAL
5
A
SER
6
n
6
SER
6
A
GLU
7
n
7
GLU
7
A
TRP
8
n
8
TRP
8
A
THR
9
n
9
THR
9
A
GLU
10
n
10
GLU
10
A
TYR
11
n
11
TYR
11
A
LYS
12
n
12
LYS
12
A
THR
13
n
13
THR
13
A
ALA
14
n
14
ALA
14
A
ASP
15
n
15
ASP
15
A
GLY
16
n
16
GLY
16
A
LYS
17
n
17
LYS
17
A
THR
18
n
18
THR
18
A
TYR
19
n
19
TYR
19
A
TYR
20
n
20
TYR
20
A
TYR
21
n
21
TYR
21
A
ASN
22
n
22
ASN
22
A
ASN
23
n
23
ASN
23
A
ARG
24
n
24
ARG
24
A
THR
25
n
25
THR
25
A
LEU
26
n
26
LEU
26
A
GLU
27
n
27
GLU
27
A
SER
28
n
28
SER
28
A
THR
29
n
29
THR
29
A
TRP
30
n
30
TRP
30
A
GLU
31
n
31
GLU
31
A
LYS
32
n
32
LYS
32
A
PRO
33
n
33
PRO
33
A
GLN
34
n
34
GLN
34
A
GLU
35
n
35
GLU
35
A
LEU
36
n
36
LEU
36
A
LYS
37
n
37
LYS
37
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
TYR
11
A
N
TYR
11
A
O
TYR
19
A
O
TYR
19
A
N
ASN
22
A
N
ASN
22
A
O
GLU
27
A
O
GLU
27
8
A
A
H
O
ASN
GLU
22
27
1.58
1
A
ARG
24
0.233
SIDE CHAIN
2
A
ARG
24
0.230
SIDE CHAIN
3
A
ARG
24
0.232
SIDE CHAIN
4
A
ARG
24
0.123
SIDE CHAIN
5
A
ARG
24
0.122
SIDE CHAIN
6
A
ARG
24
0.307
SIDE CHAIN
7
A
ARG
24
0.244
SIDE CHAIN
8
A
ARG
24
0.305
SIDE CHAIN
9
A
ARG
24
0.304
SIDE CHAIN
10
A
ARG
24
0.244
SIDE CHAIN
1
A
ALA
2
-171.97
120.95
1
A
VAL
5
44.62
85.72
1
A
SER
6
170.62
-172.06
1
A
GLN
34
31.10
36.11
1
A
GLU
35
-153.85
24.15
2
A
ALA
2
52.14
97.57
2
A
THR
3
-114.10
58.10
2
A
VAL
5
64.23
128.79
2
A
SER
6
81.97
-160.15
2
A
GLN
34
-68.71
59.29
2
A
GLU
35
-178.32
30.94
2
A
LEU
36
-151.74
58.63
3
A
THR
3
-119.66
68.98
3
A
ALA
4
-108.04
49.53
3
A
VAL
5
42.89
81.64
3
A
SER
6
171.32
-166.71
3
A
ARG
24
-38.63
-30.78
3
A
GLN
34
-67.13
57.91
3
A
GLU
35
-176.27
31.08
3
A
LEU
36
-154.24
51.60
4
A
ALA
2
68.67
114.47
4
A
ALA
4
-111.21
50.28
4
A
VAL
5
59.43
136.98
4
A
SER
6
78.83
-162.21
4
A
ARG
24
-39.77
-31.12
4
A
GLN
34
-68.48
59.97
4
A
GLU
35
-177.40
31.29
4
A
LEU
36
-148.56
41.62
5
A
ALA
2
-177.93
132.59
5
A
ALA
4
-110.83
50.78
5
A
VAL
5
46.50
81.72
5
A
SER
6
166.72
-170.77
5
A
GLN
34
-68.54
59.62
5
A
GLU
35
-177.82
31.69
5
A
LEU
36
-152.76
48.63
6
A
ALA
2
-179.82
-76.07
6
A
THR
3
-158.93
72.06
6
A
ALA
4
-106.45
50.07
6
A
VAL
5
55.44
77.94
6
A
SER
6
167.71
-162.47
6
A
GLU
35
-176.37
32.66
6
A
LEU
36
-151.05
45.52
7
A
ALA
2
-166.05
94.30
7
A
ALA
4
-98.18
50.60
7
A
VAL
5
61.02
129.22
7
A
SER
6
66.76
-91.37
7
A
GLU
7
36.00
30.57
7
A
GLN
34
30.54
35.35
7
A
GLU
35
-156.80
24.62
8
A
ALA
2
-153.85
46.11
8
A
THR
3
-97.75
45.36
8
A
ALA
4
-96.69
50.95
8
A
VAL
5
65.01
81.85
8
A
SER
6
175.55
-167.14
8
A
GLN
34
-68.81
59.33
8
A
GLU
35
-177.25
32.07
8
A
LEU
36
-153.35
60.78
9
A
ALA
2
62.14
121.09
9
A
THR
3
-150.62
76.53
9
A
ALA
4
-98.43
48.49
9
A
VAL
5
65.36
86.95
9
A
SER
6
171.34
-159.85
9
A
PRO
33
-84.62
49.93
9
A
GLN
34
30.91
37.28
9
A
GLU
35
-154.69
25.05
10
A
THR
3
-161.11
73.37
10
A
ALA
4
-107.45
49.21
10
A
VAL
5
63.31
81.94
10
A
SER
6
167.61
-166.62
10
A
GLN
34
31.27
35.96
10
A
GLU
35
-154.17
23.86
FORMIN BINDING PROTEIN
FBP28WW domain from Mus musculus
1
N
N
SH3 DOMAIN
SH3 DOMAIN, WW DOMAIN, FBP28, SIGNAL TRANSDUCTION
Q61051
UNP
1
Q61051
1
26
1E0L
1
37
Q61051
A
1
1
37
3
anti-parallel
anti-parallel
A
TRP
8
A
TRP
8
A
THR
13
A
THR
13
A
LYS
17
A
LYS
17
A
ASN
23
A
ASN
23
A
LEU
26
A
LEU
26
A
TRP
30
A
TRP
30
1
P 1